SkyView Investment Advisors’s Zomedica Corp. ZOM Stock Holding History

SkyView Investment Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-41,650	Closed	-$22K	–	600
2021 Q3	$22K	Sell	41,650 -1,350	-3%	-$797	0.01%	359
2021 Q2	$68K	Hold	43,000	–	–	0.03%	189
2021 Q1	$68K	Buy	+43,000	New	+$70.3K	0.03%	197

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

PWMG

Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return

SkyView Investment Advisors's ZOM Position: Q4 2021 in Review

SkyView Investment Advisors sold out of Zomedica Corp. (ZOM) in Q4 2021, closing a stake of 41,650 shares — an estimated $22K sold.

SkyView Investment Advisors first reported a position in ZOM in Q1 2021 and held it in 3 quarters. The position peaked at $68K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q4 2021.

SkyView Investment Advisors reported no remaining Zomedica Corp. position as of Q4 2021 after selling out during the quarter.
SkyView Investment Advisors sold 41,650 Zomedica Corp. shares in Q4 2021, an estimated $22K.
SkyView Investment Advisors first reported a position in Zomedica Corp. in Q1 2021 and held it in 3 quarters.
SkyView Investment Advisors's Zomedica Corp. position peaked at $68K in Q2 2021.
107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2021.

Based on SkyView Investment Advisors's 13F filing for Q4 2021, filed 18 Feb 2022.